ArticleFrontiers in public health2024
Awareness, attitude, and acceptance of newborn screening for sickle cell disease among health workers and caregivers at primary healthcare centers in Gwagwalada Area Council, Federal Capital Territory, Abuja, Nigeria.
Article in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Continuum of care after newborn screening for sickle cell disease: Multinational evidence from a systematic review and meta-analysis.British journal of haematology · 2026Article
- Creative and Adaptive Solutions for Early Diagnosis of Sickle Cell Disease in Sub-Saharan Africa.American journal of hematology · 2026Review
- Newborn Screening for Hemoglobinopathies and Thalassemias: Brief History, Recent Activities, and Global Status-2026.International journal of neonatal screening · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Introduction: Newborn Screening (NBS) is a public health program designed to identify and provide early interventions for infants with genetic disorders such as Sickle Cell Disease (SCD). Lack of awareness and unwillingness to participate in the NBS by caregivers and some healthcare workers are major contributing factors impeding NBS for SCD. Objective: To evaluate the level of awareness and acceptance of NBS for SCD and the determinant factors influencing caregivers in Gwagwalada Area Council of the Federal Capital Territory, Abuja, Nigeria. Methods: The study employed a descriptive, quantitative design using questionnaires administered to healthcare workers and caregivers at immunization and antenatal clinics of 10 selected Primary Healthcare Centers (PHC) in Gwagwalada Area Council of the Federal Capital Territory, Abuja, Nigeria. Result: A total of 357 participants, comprising 301 caregivers and 56 health care workers responded to the questionnaires. Among the caregivers, 171 (57.2%) were not aware of NBS for SCD. Two hundred and ninety (97%) expressed willingness to participate in the NBS. However, 32 (10.6%) indicated reluctance to accept positive results of SCD. The majority, 175 (59.1%) of the caregivers strongly agreed that NBS for SCD helps in the early detection and management of SCD, while 7 (2.4%) disagreed. Notably 272 (90.4%) of the caregivers had secondary and tertiary education. Among the healthcare workers, 39 (73.6%) were aware of NBS for SCD and 30 (73.2%) have recommended it to caregivers. Conclusion: This study revealed a low level of awareness of NBS for SCD among caregivers. However, there was a high level of acceptance among them. The level of awareness is high among healthcare workers. Education emerged as the major factor determining the knowledge and attitude of caregivers toward NBS for SCD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.